Skip to main content
Caplight Logo









PharMolix

PharMolix

Private
BeijingHealthcare & Life Scienceshttps://pharmolix.com/zh

Last Round

Angel

Aug 14, 2024

Company Overview

PharMolix operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was an Angel round in August 2024.

PharMolix is a biotechnology company that develops AI-powered foundation models and conversational assistants for the biomedical and drug discovery industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PharMolix Comparables

Compare PharMolix with similar companies based on industry and business-model similarity.

PharMolix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chan Zuckerberg Biohub
81%
Genesis Molecular AI
76%
Cradle
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PharMolix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelAug 14, 2024
SeedAug 14, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Mu Qiao

Co-founder & Chief Technology Officer

Founding Team

Jerry Xing

COO

Executive Team

For institutional investors. Book with your work email.

PharMolix Investors

Notable investors and investment history

PharMolix investors
InvestorRounds
Dalton VentureAngel
WestSummit CapitalAngel
讯飞创投Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2024

    Grew 150% QoQ from 2 to 5 employees.

  • Aug 14, 2024

    WestSummit Capital led the round.

Book a demo to see all signals

For institutional investors. Book with your work email.

PharMolix Filings

Explore SEC and related filing metadata, where available.

PharMolix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PharMolix's valuation, stock price, and market status.

Is PharMolix a public or private company?

PharMolix is a private company.

What is the current stock price of PharMolix?

PharMolix is a private company, so its shares have no public market price. Caplight tracks PharMolix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PharMolix worth (valuation)?

Valuation information for PharMolix is not publicly available.

Can I buy PharMolix stock?

PharMolix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PharMolix's last funding round?

PharMolix's most recent funding round was Angel on August 14, 2024.

Who are the main investors in PharMolix?

Key investors in PharMolix include WestSummit Capital.

Will PharMolix IPO soon?

No public IPO plans have been announced for PharMolix.

How can I track PharMolix secondary market activity?

Caplight tracks bids, offers, and trades in PharMolix's shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range7
Year Founded2023
Last FundingAug 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?